RxDoctor Payments Data

Babafemi Pratt, MD

Vascular Surgery · Dallas, TXNPI 1174773873

Payments from drug & device makers

What this record shows

This record is dominated by other: $68,917 of the $87,432 with a category attached, or 78.8%. Angiodynamics, Inc. accounts for 89.0% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2022 at $56,371 and has fallen 98.3% since, to $946 in 2025. Among vascular surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$87,432in general payments, 2019–2025

Across 240 payments — averaging $364.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$78K
  • Boston Scientific$4K
  • Veryan Medical Incorporated$1K
  • Medtronic$1K
  • Cardiovascular Systems Inc.$868
  • Abbott$604
  • plus $2K from 20 others

What the payments were for

  • Consulting fees$1,6002%
  • Travel & lodging$3,8394%
  • Food & beverage$9,33011%
  • Education$3,7454%
  • Other$68,91779%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$87,432 in reported general payments places this provider in the 90th percentile of 347 vascular surgery providers in Texas.

See all vascular surgery providers in Texas

Medicare billing

Part B allowed, 2024
$685,568
Medicare patients
79
Services billed
5,356

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate70$554
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$288
Diclofenac Sodium11$275
Methocarbamol14$83

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →